Current Price $5.33 Premium Investing Services Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services. View Premium Services Making the world smarter, happier, and richer. ...
the Zacks Rank stock-rating systemhas more than doubled the S&P 500 with an average gain of +24.08% per year.(These returns cover a period from January 1, 1988 through May 6, 2024.)
the closing price of our common stock on the Nasdaq Global Select Market ranged from $46.36 to $108.06. Factors that have caused and could cause in the future volatility in the market price of our common stock include, but are not limited to: announcements concerning any of the clinical tria...
BioMarin Pharmaceutical Inc. (BMRN) : Free Stock Analysis Report Cytokinetics, Incorporated (CYTK) : Free Stock Analysis Report CytomX Therapeutics, Inc. (CTMX) : Free Stock Analysis Report Castle Biosciences, Inc. (CSTL) : Free Stock Analysis Report To read this article on Zacks.com click h...
Goldman Sachs issues surprising gold price target for 2025 The investment firm's analysts share their views about the precious metal. TSLA Investing News, Analysis, and Tips Feb 21, 2025 10:13 AM EST UnitedHealth stock plunges on report of DoJ Medicare Advantage probe ...
Goldman Sachs issues surprising gold price target for 2025 The investment firm's analysts share their views about the precious metal. TSLA Investing News, Analysis, and Tips Feb 21, 2025 10:13 AM EST UnitedHealth stock plunges on report of DoJ Medicare Advantage probe ...